Bioseal Dural Sealing Study BIOS-14-001

Key facts

Sponsor

Guangzhou Bioseal Biotechnology Co., Ltd.

Principal Investigator

Ying Mao, MD, PhD

Hua Shan Hospital, Shanghai Medical College, Fudan University

Intervention

Bioseal(biological)

Enrollment

200 enrolled

Eligibility

18 years · All sexes

Timeline

2017 – 2019

Study locations (10)

• Xuanwu Hospital Capital Medical University, Beijing, Beijing Municipality, China
• The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
• ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
• The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
• The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• TongJi Hospital, TongJi Medical College of HUST, Wuhan, Hubei, China
• The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
• The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
• The First Hospital of Jilin University, Changchun, Jilin, China
• Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, Shanghai Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.